# Cardinal Health, Inc.  Share Price Target ‘$114.08’, now 9.0% Upside Potential

- Link: https://www.directorstalkinterviews.com/cardinal-health-inc.share-price-target-114.08-now-9.0-upside-potential/4121162176
- Published: 2024-06-25T14:55:55+01:00
- Author: Charlotte Edwards

**Cardinal Health, Inc.** with ticker code (CAH) have now 15 market analysts covering
the stock. The analyst consensus now points to a rating of ‘buy’. The range between
the high target price and low target price is between $129.00 and $95.00 suggesting
an average analyst share price target price of $114.08. (at the time of writing).
Now with the previous closing price of $104.63 and the analysts are correct then
we can expect a percentage increase in value of 9.0%. There is a 50 day moving average
of $100.63 and the 200 day moving average is $101.77. The total market capitalization
for the company now stands at 25.55B. The stock price for the company is currently
$104.90 USD

 The potential market cap would be $27,857,828,295 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 46.42, revenue per share of $891.20
and a 2.92% return on assets.

Cardinal Health, Inc. is a globally integrated healthcare services and products 
company. The Company is focused on providing customized solutions for hospitals,
healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories,
physician offices and patients in the home. The Company also provides pharmaceuticals
and medical products and solutions. The Company’s segments include Pharmaceutical
and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical,
specialty pharmaceutical and over-the-counter healthcare and consumer products in
the United States. The Medical segment manufactures, sources and distributes Cardinal
Health branded medical, surgical and laboratory products, which are sold in the 
United States, Canada, Europe, Asia and other markets. The Company connects patients,
providers, payers, pharmacists and manufacturers for integrated care coordination
and patient management.

Share on: